Showing results (51-60 of 80) with videos related to
Sort By:
Pageof 8
The Pediatric Infectious Disease Journal|February 15, 2001
Acute otitis media caused by Streptococcus pneumoniae in children's hospitals between 1994 and 1997E R Wald, E O Mason, J S Bradley, et al.Chemotherapy|January 1, 1990
Pharmacokinetics and cerebrospinal fluid (CSF) concentrations of vancomycin in pediatric patients undergoing CSF shunt placementP Fan-Havard, M C Nahata, M H Bartkowski, et al.Chemotherapy|January 1, 1990
Pharmacokinetics and cerebrospinal fluid concentration of nafcillin in pediatric patients undergoing cerebrospinal fluid shunt placementM C Nahata, P Fan-Havard, E J Kosnik, et al.Pediatric Cardiology|January 1, 1982
Cardiomyopathy in a child with hypereosinophilic syndromeT A Olson, R Virmani, R A Ansinelli, et al.Medical and Pediatric Oncology|January 1, 1988
Congenital anomalies associated with rhabdomyosarcoma: an autopsy study of 115 cases. A report from the Intergroup Rhabdomyosarcoma Study Committee (representing the Children's Cancer Study Group, the Pediatric Oncology Group, the United Kingdom Children's Cancer Study Group, and the Pediatric Intergroup Statistical Center)F B Ruymann, H R Maddux, A Ragab, et al.Cancer|June 15, 1982
Soft-tissue sarcoma of the trunk in childhood. Results of the intergroup rhabdomyosarcoma studyR B Raney, A H Ragab, F B Ruymann, et al.Journal of Clinical Apheresis|January 14, 1999
Mobilization of peripheral blood stem cells in children using G-CSF after carboplatin containing myelosuppressive chemotherapyA M Rauck, F B Ruymann, K Klopfenstein, et al.Cancer Clinical Trials|January 1, 1979
Evaluation of intensified chemotherapy in children with advanced rhabdomyosarcoma (clinical groups III and IV). The Intergroup Rhabdomyosarcoma Study (IRS) Committee of the Cancer and Leukemia Group B Children's Cancer Study Group, Southwest Oncology GroupR B Raney, E A Gehan, H M Maurer, et al.Cancer|July 1, 1983
Hepatic failure secondary to indicine N-oxide toxicity. A Pediatric Oncology Group StudyB A Cook, J R Sinnhuber, P J Thomas, et al.Chest|November 21, 1997
Pharmacokinetics and safety of tobramycin after once-daily administration in patients with cystic fibrosisR D Bates, M C Nahata, J W Jones, et al.Pageof 8